Europe news
fromwww.dw.com
3 months agoLecanemab Alzheimer's therapy approved in Europe DW 04/15/2025
Lecanemab, the first Alzheimer's drug targeting disease processes, approved by the European Commission for early-stage treatment.
"The unusually long time that they have spent considering the drug suggests that this has not been an easy or straightforward decision," said psychiatrist Robert Howard at University College London in a statement to the UK Science Media Centre.